'Special K' could relieve depression

June 7, 2012
Professor Colleen Loo

(Medical Xpress) -- Recreational drug and anaesthetic, ketamine, is being trialled in people with severe depression and is providing almost instant relief from symptoms, offering fresh hope of a quick new way to manage the illness at its worst.

Ketamine, known colloquially as “Special K”, has been shown to alleviate in a matter of minutes or hours instead of the weeks it can take some conventional medications to treat the illness.

University of New South Wales researchers are leading the Australia-first clinical trial of to determine if it could be the next frontier in treating depression, which affects around 15 per cent of the population.

Professor Colleen Loo, from UNSW’s School of Psychiatry and the Black Dog Institute, says while traditional antidepressant drugs remain useful, ketamine is envisaged as an additional treatment option, not a replacement.

“The magnitude of improvement we’re seeing within 24 hours is just astounding compared to existing antidepressant treatments,” Professor Loo says.

“The only other antidepressant treatment that comes anything close to it is electro-convulsive therapy, or ECT, the most effective proven treatment for depression.”

Researchers are investigating the body’s response to ketamine by administering a range of small doses in the placebo-controlled trial, given by intravenous infusion under careful medical monitoring.

Ketamine works on a different part of the brain from other traditional antidepressants, which is helping researchers understand more about the brain and its role in depression.

“It’s a paradigm shift. All the other existing antidepressant medications work on receptor systems like serotonin, noradrenaline and dopamine, whereas this works on the glutamate system,” Professor Loo says.

A successful, ongoing trial could mean ketamine will be used in Australia in clinical settings within a decade.

Explore further: Ketamine helps see how the brain works in clinical depression

More information: Ketamine has so far been successfully trialled on a handful of people, with more participants being recruited. Anyone interested in participating in the trial should email n.katalinic@unsw.edu.au , contact 02 9113 1637 or visit the Black Dog Institute website for more information.
Candidates for the treatment are those adults with severe depression in need of medication but who haven’t responded to traditional treatments.

Related Stories

Ketamine helps see how the brain works in clinical depression

June 16, 2011
(Medical Xpress) -- In a new study published in Nature, Lisa Monteggia from the University of Texas Southwestern Medical Center looks at how the drug ketamine, typically used as an anesthetic or a popular recreational drug ...

Ketamine improved bipolar depression within minutes

May 30, 2012
Bipolar disorder is a serious and debilitating condition where individuals experience severe swings in mood between mania and depression. The episodes of low or elevated mood can last days or months, and the risk of suicide ...

Drug boosts growth factor to jump-start rapid antidepressant response

June 22, 2011
(Medical Xpress) -- A study in mice has pinpointed a pivotal new player in triggering the rapid antidepressant response produced by ketamine. By deactivating a little-known enzyme, the drug takes the brakes off rapid synthesis ...

Recommended for you

Psychopaths are better at learning to lie, say researchers

July 25, 2017
Individuals with high levels of psychopathic traits are better at learning to lie than individuals who show few psychopathic traits, according to a study published in the open access journal Translational Psychiatry. The ...

Visual clues we use during walking and when we use them

July 25, 2017
(Medical Xpress)—A trio of researchers with the University of Texas and Rensselaer Polytechnic Institute has discovered which phase of visual information processing during human walking is used most to guide the feet accurately. ...

Toddlers begin learning rules of reading, writing at very early age, study finds

July 25, 2017
Even the proudest of parents may struggle to find some semblance of meaning behind the seemingly random mish-mash of letters that often emerge from a toddler's first scribbled and scrawled attempts at putting words on paper.

Using money to buy time linked to increased happiness

July 24, 2017
New research is challenging the age-old adage that money can't buy happiness.

Exposure to violence hinders short-term memory, cognitive control

July 24, 2017
Being exposed to and actively remembering violent episodes—even those that happened up to a decade before—hinders short-term memory and cognitive control, according to a study published in the Proceedings of the National ...

Researchers pave new path toward preventing obesity

July 24, 2017
People who experience unpredictable childhoods due to issues such as divorce, crime or frequent moves face a higher risk of becoming obese as adults, according to a new study by a Florida State University researcher.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Eventide
1 / 5 (1) Jun 08, 2012
Ecstasy deserves a shot at depression treatments trials too.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.